Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19

Due to the rapid, vast, and emerging global spread of the Coronavirus Disease 2019 (COVID-19) pandemic, many drugs were quickly repurposed in a desperate attempt to unveil a miracle drug. Ivermectin (IVM), an antiparasitic macrocyclic lactone, was tested and confirmed for its in vitro antiviral acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Awad, Hoda, Hassan, Basmala, Dweek, Sara, Aboelata, Yasmeen, Rawas-Qalaji, Mutasem, Ahmed, Iman Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506580/
https://www.ncbi.nlm.nih.gov/pubmed/36145289
http://dx.doi.org/10.3390/ph15091068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506580/
https://www.ncbi.nlm.nih.gov/pubmed/36145289
http://dx.doi.org/10.3390/ph15091068

Ejemplares similares